Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, December 21, 2022

Trend Review of Traditional Chinese Medicine Studies on Pharmacopuncture Treatment for Post-Stroke Depression

If you have to treat depression you're doing it all wrong. The correct course is to completely prevent depression by having EXACT 100% REHAB PROTOCOLS!. Your patients will be too busy counting reps and looking forward to recovery.

 Trend Review of Traditional Chinese Medicine Studies on Pharmacopuncture Treatment for Post-Stroke Depression

Journal of Oriental Neuropsychiatry , Volume 32(3) , Pgs. 235-245.

NARIC Accession Number: I248455.  What's this?
Author(s): Geumju Song; Hyunjin Khang; Jiyeon Oh; Jongmin Kim; Sangbeom Kim; Sejin Park; Yeogyeong Lee.
Publication Year: 2021.
Abstract: The aim of this study was to provide clinical evidence of pharmacopuncture treatment for post-stroke depression by reviewing randomized controlled trials on Traditional Chinese medicine pharmacopuncture, a combination of herbal medicine and acupuncture, for post-stroke depression. To this end, randomized controlled trials on pharmacopuncture treatment for post-stroke depression were searched from the China National Knowledge Infrastructure (CNKI), and literature searches of English and Chinese databases were performed. Selected literature was assessed with the Jadad scale. Twelve papers were selected from 20 studies. The following results were obtained: 1) Pharmacopuncture was used for post-stroke depression; 2) Dengzhan-Xixin was the most used injection medicine for post-stroke depression; 3) BaiHui (GV20) was the most used in pharmacopuncture treatment; 4) Based on the Hamilton Depression Rating Scale (HAMD), it was confirmed that all studies using pharmacopunture had significant efficacy. For the treatment of post-stroke depression, Dengzhans-Xixin was commonly used as an injectable medication. Additional research studies on pharmacopuncture including its practical use are needed.
Descriptor Terms: Affirmative action, Developmental disabilities, Hidden disabilities, Intellectual disabilities, Treatment.
Language: Korean
Geographic Location(s): Republic of Korea, South Asia.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: https://doi.org/10.7231/jon.2021.32.3.235.

Citation: Geumju Song, Hyunjin Khang, Jiyeon Oh, Jongmin Kim, Sangbeom Kim, Sejin Park, Yeogyeong Lee. (2021). Trend Review of Traditional Chinese Medicine Studies on Pharmacopuncture Treatment for Post-Stroke Depression.  뇌졸중 후 우울증의 약침치료에 대한 중의학 임상논문 연구동향.  Journal of Oriental Neuropsychiatry , 32(3), Pgs. 235-245. Retrieved 12/21/2022, from REHABDATA database.

No comments:

Post a Comment